Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …
被引用次数：232 相关文章

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …
[PDF] unicancer.fr

[PDF][PDF] Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - Lancet …, 2020 - icm.unicancer.fr
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - Lancet …, 2020 - hal.science
Background: Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - Elsevier
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - europepmc.org
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …
[PDF] academia.edu

[PDF][PDF] Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - Lancet …, 2020 - academia.edu
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …

[引用][C] Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - cir.nii.ac.jp
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation
therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a …
[PDF] hal.science

[PDF][PDF] Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - 2020 - hal.science
Background Adjuvant radiotherapy (aRT) reduces the risk of biochemical failure in prostate
cancer patients following radical prostatectomy (RP). The GETUG-AFU 17 study, compared …